Takeda agreed to a senior short-term loan agreement to borrow up to 500 billion Japanese Yen ($4.47 million).
Here's what you should know:
1. The loan will finance a portion of Takeda's Shire acquisition.
2. Takeda has yet to hear whether the European regulatory commission will clear the deal, but both companies expect the deal to be approved.
3. Takeda's $62 billion acquisition will make it one of the world's largest and most indebted drug makers.